ImmunoGen, Inc.
IMGNDelisted Feb 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000855654
ImmunoGen, Inc. was delisted on Feb 12, 2024; its insiders filed their last Form 4 on Feb 12, 2024; 327 institutions reported holding it in 13F filings for Q4 2023, worth $7.54B in total; Maverick Capital was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding ImmunoGen, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 216 | 222 | +6 |
| Shares | 196.1M | 196.8M | +733.4K (+0.4%) |
| Value | $882.4M | $942.2M | +$59.8M (+6.8%) |
New holders (29)
Institutions that held ImmunoGen, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (23)
Institutions that held ImmunoGen, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Driehaus Capital Management LLC | 330,909 | $1.49M |
| Altium Capital Management LP | 280,000 | $1.26M |
| Bridger Management, LLC | 278,000 | $1.25M |
| Walleye Capital LLC | 215,198 | $968.0K |
| Algert Global LLC | 162,237 | $730.0K |
| Altshuler Shaham Ltd | 129,000 | $581.0K |
| Norges Bank | 114,900 | $517.0K |
| Balyasny Asset Management LLC | 109,741 | $493.0K |
| Occudo Quantitative Strategies LP | 77,811 | $350.0K |
| Parallax Volatility Advisers, L.P. | 76,016 | $342.0K |
| BIT Capital GmbH | 66,700 | $300.1K |
| Lazard Asset Management LLC | 29,389 | $132.0K |
| National Asset Management, Inc. | 16,864 | $76.0K |
| SeaCrest Wealth Management, LLC | 3,625 | $16.0K |
| Captrust Financial Advisors | 2,016 | $9.00K |
| Prospera Financial Services Inc | 521 | $2.00K |
| Fifth Third Bancorp | 300 | $1.00K |
| Toronto Dominion Bank | 194 | $1.00K |
| Zullo Investment Group, Inc. | 152 | $1.00K |
| Venture Visionary Partners LLC | 130 | $585 |
| First Bank & Trust | 11 | $0 |
| Bogart Wealth, LLC | 50 | $0 |
| CoreCap Advisors, LLC | 67 | $0 |